LWA
TMO icon

Lineweaver Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Lineweaver Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.08M Buy
3,087
+39
+1% +$23.2K 0.24% 87
2026
Q2 		$1.53M Buy
3,048
+126
+4% +$60.5K 0.18% 101
2026
Q1 		$1.44M Sell
2,922
-108
-4% -$58.6K 0.19% 95
2025
Q4 		$1.76M Buy
3,030
+39
+1% +$22.1K 0.24% 81
2025
Q3 		$1.45M Sell
2,991
-94
-3% -$43.8K 0.21% 88
2025
Q2 		$1.25M Sell
3,085
-178
-5% -$74.4K 0.2% 86
2025
Q1 		$1.62M Buy
3,263
+71
+2% +$38.5K 0.28% 75
2024
Q4 		$1.66M Buy
3,192
+1,568
+97% +$862K 0.31% 64
2024
Q3 		$1.01M Sell
1,624
-28
-2% -$16.6K 0.19% 83
2024
Q2 		$914K Buy
1,652
+58
+4% +$33.2K 0.19% 83
2024
Q1 		$927K Sell
1,594
-6
-0.4% -$3.37K 0.22% 83
2023
Q4 		$850K Sell
1,600
-87
-5% -$42.1K 0.22% 82
2023
Q3 		$854K Buy
1,687
+21
+1% +$11.2K 0.25% 67
2023
Q2 		$869K Sell
1,666
-16
-1% -$8.63K 0.25% 69
2023
Q1 		$970K Sell
1,682
-9
-0.5% -$5.07K 0.3% 65
2022
Q4 		$931K Sell
1,691
-71
-4% -$37.6K 0.28% 69
2022
Q3 		$891K Buy
1,762
+75
+4% +$42K 0.29% 62
2022
Q2 		$916K Sell
1,687
-1,138
-40% -$626K 0.3% 59
2022
Q1 		$1.67M Buy
2,825
+55
+2% +$31.6K 0.48% 42
2021
Q4 		$1.85M Sell
2,770
-49
-2% -$30.6K 0.53% 34
2021
Q3 		$1.61M Buy
2,819
+1,198
+74% +$658K 0.49% 37
2021
Q2 		$818K Buy
1,621
+34
+2% +$16K 0.27% 56
2021
Q1 		$724K Buy
1,587
+322
+25% +$154K 0.26% 53
2020
Q4 		$589K Buy
1,265
+103
+9% +$48.3K 0.23% 49
2020
Q3 		$513K Buy
1,162
+145
+14% +$59.9K 0.23% 51
2020
Q2 		$368K Buy
1,017
+84
+9% +$28.2K 0.19% 54
2020
Q1 		$272K Buy
+933
New +$294K 0.17% 60

Other funds holding TMO

SP
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
CIPU
Caledonia Investments plc (UK) London England, United Kingdom $890M AUM 1.23% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

Lineweaver Wealth Advisors's TMO Position: Q3 2026 in Review

Lineweaver Wealth Advisors increased its Thermo Fisher Scientific (TMO) stake by 1.3% in Q3 2026, buying an estimated $23.2K and bringing the position to 3,087 shares worth $2.08M. The position accounts for 0.24% of the portfolio, ranked #87.

Lineweaver Wealth Advisors first reported a position in TMO in Q1 2020 and has held it in 27 quarters since. 302 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Lineweaver Wealth Advisors held 3,087 shares of Thermo Fisher Scientific worth $2.08M as of Q3 2026.
  • Lineweaver Wealth Advisors bought 39 Thermo Fisher Scientific shares in Q3 2026, an estimated $23.2K.
  • Thermo Fisher Scientific made up 0.24% of Lineweaver Wealth Advisors's portfolio in Q3 2026, its #87 holding.
  • Lineweaver Wealth Advisors first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 27 quarters since.
  • 302 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Lineweaver Wealth Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.